Approved Hospital Formulary
Add Formweb to your mobile device
Search results for:
HYDROmorphone
HYDROmorphone
Brand names: Dilaudid, Dilaudid-5, Dilaudid-HP, HYDROmorphone HCl
| Form | Strength |
|---|---|
| LIQUID, ORAL | 1 mg/mL |
| SOLUTION, INJECTABLE | 1 mg/mL; 2 mg/mL; 4 mg/mL; 10 mg/mL |
| SUPPOSITORY, RECTAL | 3 mg |
| TABLET, ORAL | 2 mg; 4 mg |
Last updated: Nov. 30, 2021
- High Alert: CAUTION: See High-Alert Medication Policy
- RCRA: Disposal
- RCRA: Management of Pharmaceutical Waste Policy
- Do Not Crush: ER Tablet
- Black Box Warning: Respiratory depression risk; abuse potential
- REMS: Opioid Analgesic REMS
Class II
Patient Controlled Analgesia (PCA): See Policy 900.4103
Hydromorphone may be given via hypodermoclysis (HDC/subcutaneous infusion). See Procedure 904.4991
Use in mechanically ventilated patients, See the Pain, Agitation and Delirium Protocol (aka "PAD") Protocol 901.6008
Infusion Concentrations and Ranges:
Adult General Titration Ranges and Administration (weight based dosing): See Handout (updated Aug 2016)